Prostate Cancer accounts for 4.5% share of global Oncology clinical trial activity in 2020
Prostate Cancer accounted for a 4.5% share of the global clinical trials within the Oncology therapy area in 2020, registering…
Prostate Cancer accounted for a 4.5% share of the global clinical trials within the Oncology therapy area in 2020, registering…
Pain accounted for a 47.7% share of the global clinical trials within the Central Nervous System therapy area in 2020,…
Ovarian Cancer accounted for a 4.4% share of the global clinical trials within the Oncology therapy area in 2020, registering…
Lymphoma accounted for a 9.8% share of the global clinical trials within the Oncology therapy area in 2020, registering a…
Leukemia accounted for a 10.6% share of the global clinical trials within the Oncology therapy area in 2020, registering a…
The global clinical trials activity saw an increase of 5.9% in Q2 2021, when compared with the rolling average of…
Rheumatoid Arthritis accounted for an 18.9% share of the global clinical trials within the Immunology therapy area in 2020, registering…
Osteoarthritis accounted for a 26.2% share of the global clinical trials within the Musculoskeletal Disorders therapy area in 2020, registering…
Hepatitis C accounted for a 0.9% share of the global clinical trials within the Infectious Disease therapy area in 2020,…
South Korea has accounted for a 3.6% share of the global clinical trials activity in 2020, registering a decrease when…